PubMed HealthSearch

PubMed · 8854236

Analyzing multivariate data in crossover designs using permutation tests.

Abstract

Studies using crossover designs typically involve observations on a large number of response variables made on each of a relatively small number of subjects. Moreover, investigators often observe the responses longitudinally over time. As the number of variates approaches the number of subjects traditional multivariate statistics based on the concept of statistical distance often are not very powerful, and when that number exceeds the total number of subjects in the study, these tests are not defined. In these situations, statisticians frequently analyze each variate separately and adjust for the multiple testing using a technique suitable for correlated data. In the case of a single variate measured repeatedly, we often make the assumption of a patterned covariance matrix and then conduct a univariate mixed-model analysis. We discuss an alternative approach using a variety of data structures in 2 x 2 crossover designs with (1) univariate response in each treatment period, (2) multivariate response in each treatment period, and (3) longitudinal repeated measures on a single variate in each treatment period.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W D Johnson, D E Mercante. 1996. Analyzing multivariate data in crossover designs using permutation tests.. https://doi.org/10.1080/10543409608835147

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).

This study examines the association between time to treatment with thrombolytic therapy and hospital outcomes in patients with acute myocardial infarction (AMI) enrolled in a national registry. A total of 71,253 patients hospitalized with AMI from June 1994 to July 1996 who received tissue plasminogen activator (t-PA) therapy in 1,474 United States hospitals were studied. In this study sample, approximately 39% of patients presented to participating hospitals within 2 hours of acute symptom onset and received t-PA; 36% were treated within 2.1 to 4 hours, 12% between 4.1 to 6 hours, and the remaining 13% thereafter. After controlling for potentially confounding factors, in-hospital death rates increased progressively with increasing delays in time of administration of t-PA. The lowest risk for dying during acute hospitalization was seen for those treated with t-PA within 2 hours of acute symptoms. No significant association was seen between time of administration of t-PA and in-hospital risk of recurrent AMI, myocardial ischemia, cardiogenic shock, major bleeding episodes, or stroke and/or intracranial bleeding. The incidence of sustained ventricular arrhythmias declined with progressively longer time to administration of t-PA. The results of this multihospital observational study suggest that patients with AMI treated earlier with t-PA are significantly more likely to survive the acute hospitalization than patients treated later. These data reinforce the benefits to be gained by treatment with t-PA as soon as possible following the onset of acute ischemic symptoms, and for community-wide efforts to reduce the duration of prehospital delay in patients with acute coronary disease.

Cross-Over Studies

[Health information in the daily local press].

OBJECTIVE: To know how much health-related information is published in the daily local press, type of information; pathologies; practical help offered, and sources. DESIGN: Crossover descriptive study. SETTING: Community. PARTICIPANTS: Health articles (events and publicity excluded) published in the newspapers of Bizkaia: Deia, Egin, Egunkaria, El Correo and El Mundo; sample included all issues from one fortnight of June and one fortnight of September of 1996. MEASUREMENTS AND MAIN RESULTS: 501 articles, which occupied 1.57% of the impressed surface, were published. 90% of the issues had health articles. 19.8% appeared in once-weekly health sections. Subjects considered as health culture were 49.9% scientific and technical information and 9.8% health habits and vaccinations. When compared with the rest of the newspaper, health sections gave more explicit advice (p = 0.04) and diferred in sources of information (p < 0.01). CONCLUSIONS: Health articles are almost daily published. The most frequent type was the spread of scientific and technical information. Current information topics are dominant. A few articles give explicit advice or referred to health habits. Acknowledgement of the sources could be improved. It would be desirable to investigate the quality of contents.

Cross-Over Studies